Vave Pharma Production ApS

CVR 44316897 · Private limited company (ApS) · Active · High risk

Vave Pharma Production ApS is a Private limited company (ApS), founded on , based in Humlebæk. The company is registered in the industry fremstilling af medicinske og dentale instrumenter samt udstyr hertil. Our model estimates a bankruptcy risk of 2.8% over the next 12 months, which is 2.0 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -99k and a net result of DKK -110k. CEO: Carsten Leonhard Knudsen.

Bankruptcy risk for Vave Pharma Production ApS

2.8%
probability of bankruptcy within 12 months
High risk

2.0 × the average (1.41%) · higher risk than 87% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO's previous bankruptcies3+ · bankruptcy rate 20.2%2.3×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Equity ratio-50%–0% · bankruptcy rate 14.8%1.7×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×

Reduces the risk

Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
CEO's other companies10–30 · bankruptcy rate 6.0%0.68×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44316897
Status
Active
Company type
Private limited company (ApS)
Founded
(3 years)
Address
Humlehaven 2
3050 Humlebæk
Municipality
Fredensborg
Industry
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)
Bankruptcies in the industry: Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Share capital
DKK 40k
Auditor
ReviTotalStatsautoriseret Revisionfirma
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 2
Missing annual reportNo
Negative equityYes
Equity ratio-3.8%
Current ratio95%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies22
Other companies at the address8
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -114kDKK -38k
Net profitDKK -110kDKK -29k
EquityDKK -99kDKK 11k
Total assetsDKK 2.6mDKK 52k
CashDKK 13kDKK 554
Short-term debtDKK 2.7mDKK 41k
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · ReviTotalStatsautoriseret Revisionfirma.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025182
21 Sep 2023 – 31 Dec 2024178

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOCarsten Leonhard KnudsenCurrent
Owner (100%)Vave Pharma Holding ApSCurrent
Owner (100%)Carsten Leonhard Knudsen
Owner (33%)Tømrerfirmaet Lindeberg ApS
FounderVave Pharma Holding ApSCurrent

The CEOs' other companies

Carsten Leonhard Knudsen – 42 other companies, of which 31 bankrupt

Address history (1 moves)

Humlehaven 2, 3050 Humlebæk
Rønnevej 70, 3730 Nexø

Other companies at the same address

Similar companies in Fredensborg

Questions and answers about Vave Pharma Production ApS

Has Vave Pharma Production ApS gone bankrupt?

No, Vave Pharma Production ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Vave Pharma Production ApS?

Our model estimates a bankruptcy risk of 2.8% over the next 12 months (high risk), which is 2.0 times the average for Danish companies.

Who is the CEO of Vave Pharma Production ApS?

Carsten Leonhard Knudsen is the CEO of Vave Pharma Production ApS.

Who is the auditor of Vave Pharma Production ApS?

Vave Pharma Production ApS most recently used ReviTotalStatsautoriseret Revisionfirma.

When was Vave Pharma Production ApS founded?

Vave Pharma Production ApS was founded on 21 September 2023.

What is the equity of Vave Pharma Production ApS?

Equity was DKK -99k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.